Is There a Survival Benefit to Neoadjuvant Versus Adjuvant Chemotherapy, Combined with Surgery for Resectable Colorectal Liver Metastases?

被引：0
|
作者：
Nir Lubezky
Ravit Geva
Einat Shmueli
Richard Nakache
Joseph M. Klausner
Arie Figer
Menahem Ben-Haim
机构：
[1] Tel-Aviv Sourasky Medical Center,Department of Surgery “B”
[2] Tel-Aviv Sourasky Medical Center,Liver Surgery Unit
[3] Tel-Aviv Sourasky Medical Center,Service for Gastrointestinal Malignancies
来源：
World Journal of Surgery | 2009年 / 33卷
关键词：
Liver Metastasis; Irinotecan; Oxaliplatin; Liver Resection; Colorectal Liver Metastasis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1028 / 1034
页数：6
相关论文
共 50 条
  • [1] Is There a Survival Benefit to Neoadjuvant Versus Adjuvant Chemotherapy, Combined with Surgery for Resectable Colorectal Liver Metastases?
    Lubezky, Nir
    Geva, Ravit
    Shmueli, Einat
    Nakache, Richard
    Klausner, Joseph M.
    Figer, Arie
    Ben-Haim, Menahem
    [J]. WORLD JOURNAL OF SURGERY, 2009, 33 (05) : 1028 - 1034
  • [2] Survival benefit of neoadjuvant chemotherapy and surgery versus surgery first for resectable colorectal liver metastases: a cohort study
    Behrenbruch, Corina
    Prabhakaran, Sowmya
    Udayasiri, Dilshan
    Hollande, Frederic
    Michael, Michael
    Hayes, Ian
    Heriot, Alexander
    Knowles, Brett
    Thomson, Benjamin
    [J]. ANZ JOURNAL OF SURGERY, 2021, 91 (06) : 1196 - 1202
  • [3] Comparison of oncological outcomes between neoadjuvant and adjuvant chemotherapy combined with surgery for resectable synchronous colorectal liver metastases
    Oh, Seung Yeop
    Kim, Do Yoon
    Kim, Young Bae
    Suh, Kwang Wook
    [J]. JOURNAL OF SURGICAL RESEARCH, 2013, 182 (02) : 257 - 263
  • [4] The survival benefit of neoadjuvant chemotherapy for resectable colorectal liver metastases with high tumor burden score
    Yoshihiko Yonekawa
    Kay Uehara
    Takashi Mizuno
    Toshisada Aiba
    Atsushi Ogura
    Toshiki Mukai
    Yukihiro Yokoyama
    Tomoki Ebata
    Yasuhiro Kodera
    Masato Nagino
    [J]. International Journal of Clinical Oncology, 2021, 26 : 126 - 134
  • [5] The survival benefit of neoadjuvant chemotherapy for resectable colorectal liver metastases with high tumor burden score
    Yonekawa, Yoshihiko
    Uehara, Kay
    Mizuno, Takashi
    Aiba, Toshisada
    Ogura, Atsushi
    Mukai, Toshiki
    Yokoyama, Yukihiro
    Ebata, Tomoki
    Kodera, Yasuhiro
    Nagino, Masato
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (01) : 126 - 134
  • [6] Adjuvant and neoadjuvant chemotherapy for patients with resectable liver metastases from colorectal cancer
    Rougier, P
    Guimbaud, R
    Mitry, E
    Vaillant, JN
    [J]. BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2003, 187 (05): : 881 - 892
  • [7] Letter to the editor: the benefit of adjuvant chemotherapy for resectable colorectal cancer liver metastases
    Chen Zhong
    Kainan Li
    Jingwang Bi
    Baocheng Wang
    [J]. International Journal of Colorectal Disease, 2013, 28 : 1455 - 1456
  • [8] Letter to the editor: the benefit of adjuvant chemotherapy for resectable colorectal cancer liver metastases
    Zhong, Chen
    Li, Kainan
    Bi, Jingwang
    Wang, Baocheng
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2013, 28 (10) : 1455 - 1456
  • [9] A combined approach of neoadjuvant chemotherapy and surgery for colorectal liver metastases
    Esposito, A
    Mancini, R
    Ettore, G
    Garufi, C
    Saracca, E
    Arcieri, S
    Cosimelli, M
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2003, 22 (04) : 197 - 202
  • [10] Integration of neoadjuvant and adjuvant chemotherapy in patients with resectable liver metastases from colorectal cancer
    Hebbar, Mohamed
    Pruvot, Francois-Rene
    Romano, Olivier
    Triboulet, Jean-Pierre
    de Gramont, Aimery
    [J]. CANCER TREATMENT REVIEWS, 2009, 35 (08) : 668 - 675
12345